by adminAdrianRamirez | Aug 14, 2017 | HempMeds Brasil, Press Releases
Sold-Out Event to Educate Brazilian Medical Community on Therapeutic Uses of Cannabis, Importation and Prescribing Rules to Provide Patients Greater Access SAN DIEGO, Aug. 14, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company...
by adminAdrianRamirez | Aug 11, 2017 | HempMeds Brasil, Media Coverage
[vc_row][vc_column][vc_column_text]Medical Marijuana, Inc. portfolio company HempMeds® Brasil was featured this week in an article about CBD oil’s growing use among patients on the nation’s popular Catraquinha website. According to the Catraquinha website, the page,...
by adminAdrianRamirez | Jul 20, 2017 | HempMeds Brasil, Press Releases
SAN DIEGO, July 20, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that it and its subsidiary HempMeds® Brasil garnered extensive media coverage across Brazil about the...
by adminAdrianRamirez | Jul 19, 2017 | HempMeds Brasil, Press Releases
Brazilian Doctors Have Been Prescribing RSHO™ to Treat Patients Suffering From Effects of ALS and Psoriasis SAN DIEGO, July 19, 2017 — Medical Marijuana, Inc. (MJNA) is the first publicly traded cannabis company in the United States. Its subsidiary HempMeds®...
by adminAdrianRamirez | Mar 30, 2017 | Company News, HempMeds Brasil, Press Releases
Company to Educate Brazilian Medical Community on Therapeutic Uses of Cannabis, Importation Rules to Provide Patients Greater Access SAN DIEGO, March 30, 2017 — Medical Marijuana, Inc. ( MJNA ), the first publicly traded cannabis company in the United States,...